Investing, Biotechnology, Venture Capital, Science, Immune System.
these strategies aim to reduce the initial peak exposure and maintain a more sustained and tolerable level of cytokine signaling over time. The authors discuss the limitations of first-generation immunocytokines, which attempted to target cytokines to tumors through tumor-associated antigens